Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

Wide-moat Medtronic received highly welcome news today as the U.S. Food and Drug Administration has (finally) approved the firm’s next-gen 780g insulin pump, and we’re leaving our $112 fair ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

After a long delay, the U.S. Food and Drug Administration has approved Medtronic's MiniMed 780G device, the company's next-generation insulin pump. Medtronic's diabetes division has been under a ...

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

Medtronic plc’s MDT most advanced automated insulin delivery (AID) system, MiniMed 780G, was recently recognized by the Fast Company in the Best World-Changing Idea, North America category as ...

Medtronic (NYSE:MDT) today shared data supporting the use of its MiniMed 780G automated insulin delivery system in a range of ...

Medtronic's MiniMed 780G insulin pump lands long-awaited FDA approval. By Andrea Park Apr 24, 2023 10:30am. Medtronic MiniMed insulin pump Type 1 diabetes. Two ...

Medtronic’s diabetes products are sold directly to patients and consist of wearable and disposable devices. ... The letter delayed the FDA’s clearance of the MiniMed 780G insulin pump until 2023.

Medtronic plans to seek an expanded label for its 780G pump for people with Type 2 diabetes, Martha told investors in February. The company is also partnering with competitor Abbott to make a CGM ...

On Oct. 4, Medtronic notified users of the 630G, 670G, 770G and 780G insulin pumps of an increased risk for shorter-than-expected battery life and less time until the pump shuts down following a ...